Scaleup programmes

Back to programmes


Cambridge Angels

Finance and Risk Capital

Impact for scaleups


UK companies backed


Follow-on investments


Investments outside London


Growth-stage investments

Key sectors

Healthcare Life Sciences & Biotech Technology & Communications


Cambridge Angels is a group of more than 60 high-net worth investors who invest in and mentor high quality early-stage and scaling companies in Cambridge, London, Oxford and throughout the UK. In 2022, Cambridge Angels invested £71.2m in 58 companies.

Typical funding requirements that Cambridge Angels meet are in the range of £150k to £1.5m – although several portfolio companies have raised significant follow-on funding from its members and the network’s VC partners over several funding rounds. There is a particular focus on deep-tech, and tools and technologies supporting healthcare.

The network’s membership has founded, invested in and led a large number of successful Cambridge-based companies in recent years, such as Paragraf, Arecor, Eagle Genomics, Privitar and Healx. In addition to providing funding, Cambridge Angels also offers expertise, contacts and directly relevant experience to early-stage and scaling companies – in what it terms “smart capital from entrepreneurs to entrepreneurs.”

Emphasis is placed upon leveraging the collective experience of the portfolio and the angels.  Sessions are hosted in which angels and a network of professionals and associates provide portfolio companies with education sessions on topics such as exits and building leadership teams.

Since inception in September 2001, Cambridge Angels has invested in excess of £150m in over 120 portfolio companies. 24 of the companies in the current portfolio are in the scaleup stage having received early-stage funding and support from Cambridge Angels at their seed stage and continuing to date.

Cambridge Angels website